Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nishida Pharmaceutical is a Japanese pharmaceutical company headquartered in Saga Prefecture, specializing in the development and manufacture of ophthalmic and dermatological products. The company produces a wide range of ethical drugs and over-the-counter medicines, with a particular emphasis on eye drops, ointments, and creams. Led by President Yoshihiro Nishida, the firm operates manufacturing facilities that adhere to strict Japanese Good Manufacturing Practice (GMP) standards. Their business model focuses on providing high-quality, reliable generic and specialty medications to the domestic Japanese market. In addition to its own branded products, the company engages in contract manufacturing for other pharmaceutical entities, leveraging its expertise in sterile liquid and semi-solid formulations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nishida Yoshihiro.